The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension.

Withdrawn

• Conditions: increased pressure in the liver; portal hypertension; 10064477

• Registration Number: NL-OMON38711
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

- Patient with cirrhosis undergoing TIPS placement
- >=18 years of age
- Signed informed consent

Exclusion Criteria

Patients with hemophilia A or von Willebrands disease

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The level of von Willebrand factor prior to, directly after, one week after,<br /><br>and one month after placement of a transjugular intrahepatic portosystemic<br /><br>shunt.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>